APA (7th ed.) Citation

S, S., Q, Y., W, C., L, L., Y, S., C, L., . . . C, L. (2026). Association between sevelamer use and outcomes in acute kidney injury with hyperphosphataemia: Evidence from the MIMIC-IV. Frontiers in pharmacology, 17, 1776446. https://doi.org/10.3389/fphar.2026.1776446

Chicago Style (17th ed.) Citation

S, Suo, Yang Q, Chen W, Luo L, Song Y, Ling C, Wang J, Wen D, and Liu C. "Association Between Sevelamer Use and Outcomes in Acute Kidney Injury with Hyperphosphataemia: Evidence from the MIMIC-IV." Frontiers in Pharmacology 17 (2026): 1776446. https://doi.org/10.3389/fphar.2026.1776446.

MLA (9th ed.) Citation

S, Suo, et al. "Association Between Sevelamer Use and Outcomes in Acute Kidney Injury with Hyperphosphataemia: Evidence from the MIMIC-IV." Frontiers in Pharmacology, vol. 17, 2026, p. 1776446, https://doi.org/10.3389/fphar.2026.1776446.